Senior insider sale
Chief Commercial Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$120.8K
2.87K shares
What this filing means
WILEY MATTHEW T. plans to sell 2.87K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $120.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2026ACC: 0001950047-26-006492
Officer· Chief Commercial Officer
Since Feb 2026
2.87K
Shares to sell
$120.8K
Approx. market value
2.87K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Services Rendered
6/25/2026
2.87KTotal acquired2.87K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2026 | Restricted Stock Vesting Under a Registered Plan Services Rendered | 2.87K | — |
| Total | 2.87K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.87K
Market value
$120.8K
6/25/2026
Total
Units
2.87K
Value
$120.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/25/2026 | 2.87K | $120.8K | NASDAQ | Planned |
| Total | 2.87K | $120.8K | ||